1.
Vikas Gupta, Ruben A. Mesa, Michael W.N. Deininger, Candido E. Rivera, Shireen Sirhan, Carrie Baker Brachmann, Helen Collins, Jun Kawashima, Yan Xin, Srdan Verstovsek. A phase 1/2, open-label study evaluating twice-daily administration of momelotinib in myelofibrosis. haematol [Internet]. 2017Jan.1 [cited 2022Aug.11];102(1):94-102. Available from: https://haematologica.org/article/view/7950